Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Carmel Pharma AB

Closing information (x1000 NOK)

Closing information 2024/09 2023/09 2022/09
Turnover 81,624 Less Arrow 70,160 Less Arrow 65,276
Financial expenses 28 Less Arrow 2 Less Arrow 1
Earnings before taxes 102,082 Less Arrow 80,907 Less Arrow 65,317
EBITDA 80,113 Less Arrow 68,695 Less Arrow 64,182
Total assets 486,989 Less Arrow 443,238 More Arrow 472,259
Current assets 1,536 More Arrow 1,774 More Arrow 14,951
Current liabilities 103,670 Less Arrow 82,305 More Arrow 119,291
Equity capital 383,319 Less Arrow 360,933 Less Arrow 352,968
- share capital 9,230 Less Arrow 8,691 Less Arrow 8,500
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/09 2023/09 2022/09
Solvency 78.7% More Arrow 81.4% Less Arrow 74.7%
Turnover per employee
Profit as a percentage of turnover 125.1% Less Arrow 115.3% Less Arrow 100.1%
Return on assets (ROA) 21.0% Less Arrow 18.3% Less Arrow 13.8%
Current ratio 1.5% More Arrow 2.2% More Arrow 12.5%
Return on equity (ROE) 26.6% Less Arrow 22.4% Less Arrow 18.5%
Change turnover 7,111 Less Arrow 3,420 More Arrow 11,139
Change turnover % 10% Less Arrow 5% More Arrow 21%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/09 2023/09 2022/09
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.